Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the framingham offspring study

Diabetes Care

Volumn 25, Issue 6, 2002, Pages 989-994

  Schaefer, Ernst J ^a   McNamara, Judith R ^a   Shah, Paulesh K ^a   Nakajima, Katsuyuki ^b   Cupples, L Adrienne ^c   Ordovas, Jose M ^a   Wilson, Peter W F ^d  

^a TUFTS MEDICAL CENTER   (United States)

^b Otsuka America Pharmaceutical   (United States)

^c BOSTON UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REMNANT LIKE PARTICLE CHOLESTEROL; REMNANT-LIKE PARTICLE CHOLESTEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL OBSERVATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BODY MASS; MIDDLE AGED; REFERENCE VALUE; SEXUAL DEVELOPMENT; UNITED STATES;

BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS; FEMALE; HUMANS; LIPOPROTEINS; MALE; MASSACHUSETTS; MIDDLE AGED; REFERENCE VALUES; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 0036595221     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.6.989     Document Type: Article

References (25)

1. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847, 1998
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
3. Genest JJ Jr, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, Silberman SR, Wilson PWF, Salem DN, Schaefer EJ: Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85:2025-2033, 1992
4. Hokanson JE, Austin MA: Plasma triglyceride levels as a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213-219, 1996
5. Brewer HB Jr, Zech LA, Gregg RE, Schwartz D, Schaefer EJ: NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med 98:623-640, 1983
6. Devaraj S, Vega G, Lange R, Grundy SM, Jailal I: Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease. Am J Med 104:445-450, 1998
7. Watanabe N, Taniguchi T, Taketoh H, Kitagawa Y, Namura H, Yoneda N, Kurimoto Y, Yamada S, Ishikawa Y: Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care 22:152-156, 1999
8. Shimizu H, Mori M, Saito T: An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria. Clin Chim Acta 221:191-196, 1993
9. Song J, Park H, Hong SH, Lee HK, Park YB, Kim JQ: Remnant-like particle cholesterol levels in Korean patients with coronary artery disease and non-insulin dependent diabetes mellitus. Clin Chem Lab Med 38:427-432, 2000
10. Mjos OD, Faergeman O, Hamilton RL, Havel RJ: Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat. J Clin Invest 56:603-615, 1975
11. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ: Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apoB-100 and anti apoA-I immunoaffinity mixed gels. Clin Chim Acta 223:53-71, 1993
12. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H: Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99:2858-2860, 1999
13. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PWF, Ordovas JM, Schaefer EJ: Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 154:229-237, 2001
14. McNamara JR, Schaefer EJ: Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 166:1-8, 1987
15. Richterich R, Dauwalder H: Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method. Schweiz Med Wochenschr 101:615-618, 1971
16. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
17. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PWF, Ordovas JM, Schaefer EJ: Remnant lipoprotein cholesterol and triglyceride: reference ranges from the Framingham Heart Study. Clin Chem 44:1224-1232, 1998
18. Miller M, Seidler A, Moalemi A, Pearson TA: Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J Am Coll Cardiol 31:1252-1257, 1998
19. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al: Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317:1237-1245, 1987
20. Frick MH, Manninen V, Huttunen JK, Heinonen OP, Tenkanen L, Manttari M: HDL-cholesterol as a risk factor in coronary heart disease: an update of the Helsinki Heart Study. Drugs 40 (Suppl. 1):7-12, 1990
21. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J, for the Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 342:410-418, 1999
22. Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study. Lancet. 344:1383-1389, 1994
23. Robins SJ, Collins D, Rubins HB: Diabetes, hyperinsulinemia and recurrent coronary events in the VA-High Density Lipoprotein Intervention Trial (VA-HIT) (Abstract). Circulation 101:847, 2000
24. Devaraj S, Hirany S, Jialal I: Ratio of remnant-like particle cholesterol to serum total triglycerides is a reliable screening test for type III dyslipidaemia. Ann Clin Biochem 37:790-791, 2000
25. Doi H, Kugiyama K, Ohgushi M, Sugiyama S, Matsumura T, Ohta Y, Oka H, Ogata N, Hirata A, Yamamoto Y, Yasue H: Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation. Arterioscler Thromb Vasc Biol 19:1918-1924, 1999